Evaluate Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Sign: Together with chemotherapy, for your treatment of adult people with locally recurrent unresectable or metastatic triple-adverse breast most cancers that have not been given prior chemotherapy for metastatic disease and whose tumours Specific programmed mobile Dying-ligand one (mixed constructive rating ≥ ten) as https://peterq973axp5.cosmicwiki.com/user